Targeting of the translocator protein 18 kDa (TSPO): A valuable approach for nuclear and optical imaging of activated microglia

Bioconjugate Chemistry

Volumn 24, Issue 9, 2013, Pages 1415-1428

  Trapani, Adriana ^a   Palazzo, Claudio ^a   De Candia, Modesto ^a   Lasorsa, Francesco Massimo ^b   Trapani, Giuseppe ^a  

^a UNIVERSITY OF BARI   (Italy)

^b CNR   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORESCENCE; FLUORESCENCE MICROSCOPY; LIGANDS; OPTICAL IMAGE STORAGE; POSITRON EMISSION TOMOGRAPHY; VISUALIZATION;

EXPERIMENTAL CONDITIONS; FLUORESCENT PROBES; IMAGING TOOLS; MICROGLIA; OPTICAL IMAGING TECHNIQUE; RADIOLIGANDS; SECOND IMAGING; SIMPLE++; TRANSLOCATORS;

PROTEINS;

CARRIER PROTEIN; CASPASE 3; CASPASE 9; N SEC BUTYL 1 (2 CHLOROPHENYL) N METHYL 3 ISOQUINOLINECARBOXAMIDE; RADIOLIGAND;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL EXPERIMENT; BLOOD BRAIN BARRIER; BRAIN REGION; CHEMICAL STRUCTURE; CHOLESTEROL TRANSPORT; CONTROLLED STUDY; DISEASE COURSE; FLUORESCENCE IMAGING; GRAY MATTER; HIV ASSOCIATED DEMENTIA; HYDROGEN BOND; IC 50; IN VITRO STUDY; ISOTOPE LABELING; LIPOPHILICITY; MALE; MICROGLIA; MITOCHONDRIAL MEMBRANE; MITOCHONDRIAL PERMEABILITY; MOLECULAR WEIGHT; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; QUANTITATIVE ANALYSIS; RADIOACTIVE WASTE; REVIEW; SIGNAL NOISE RATIO; STEROIDOGENESIS; UPREGULATION; WHITE MATTER;

ANIMALS; HUMANS; ISOQUINOLINES; LIGANDS; MICROGLIA; MICROSCOPY, FLUORESCENCE; OPTICAL IMAGING; POSITRON-EMISSION TOMOGRAPHY; RECEPTORS, GABA;

EID: 84884405607     PISSN: 10431802     EISSN: 15204812     Source Type: Journal    
DOI: 10.1021/bc300666f     Document Type: Review

References (83)

1. Venneti, S., Lopresti, B. J., and Wiley, C. A. (2006) The peripheral benzodiazepine receptor (Translocator protein 18 kDa) in microglia: from pathology to imaging Prog. Neurobiol. 80, 308-322 (Pubitemid 46107737)
2. Kraft, A. D. and Harry, G. J. (2011) Features of microglia and neuroinflammation relevant to environmental exposure and neurotoxicity Int. J. Environ. Res. Public Health 8, 2980-3018
3. Lautner, R., Mattsson, N., Scholl, M., Augutis, K., Blennow, K., Olsson, B., and Zetterberg, H. (2011) Biomarkers for microglial activation in Alzheimer's disease. Int. J. Alzheimers Dis., Art. ID 939426, doi: 10.4061/2011/939426
4. Graeber, M. B., Li, W., and Rodriguez, M. L. (2011) Role of microglia in CNS inflammation FEBS Lett. 585, 3798-3805
5. Perry, V. H., Nicoll, J. A., and Holmes, C. (2010) Microglia in neurodegenerative disease Nat. Rev. Neurol. 6 (4) 193-201
6. 11C]PK11195 challengers Eur. J. Nucl. Med. Mol. Imaging 35, 2304-2319
7. Cagnin, A., Brooks, D. J., Kennedy, A. M., Gunn, R. N., Myers, R., and Turkheimer, F. E. (2001) In-vivo measurement of activated microglia in dementia Lancet 358, 461-467 (Pubitemid 32769854)
8. Seneca, N. (2011) Recent advances in positron emission tomography imaging of brain Drug Future 36, 601-613
9. Trapani, G., Denora, N., Trapani, A., and Laquintana, V. (2012) Recent advances in ligand targeted therapy J. Drug Target. 20, 1-22
10. Papadopoulos, V., Baraldi, M., Guilarte, T. R., Knudsen, T. B., Lacapere, J. J., Lindemann, P., Norenberg, M. D., Nutt, D., Weizman, A., Zhang, M. R., and Gavish, M. (2006) Translocator protein (18 kDa): new nomenclature for the peripheral-type benzodiazepine receptor based on its structure and molecular function Trends Pharmacol. Sci. 27, 402-409 (Pubitemid 44069585)
11. Rupprecht, R., Papadopoulos, V., Rammes, G., Baghai, T. C., Fan, J., Akula, N., Groyer, G., Adams, D., and Schumacher, M. (2010) Translocator protein (18 kDa) (TSPO) as a therapeutic target for neurological and psychiatric disorders Nat. Rev. Drug Discovery 9, 971-988
12. Joseph-Liauzun, E., Delmas, P., Shire, D., and Ferrara, P. (1998) Topological analysis of the peripheral benzodiazepine receptor in yeast mitochondrial membranes supports a five-transmembrane structure J. Biol. Chem. 273, 2146-2152 (Pubitemid 28069264)
13. Korkhov, V. M., Sachse, C., Short, J. M., and Tate, C. G. (2010) Three-dimensional structure of TSPO by electron cryomicroscopy of helical crystals Structure 18, 677-687
14. Veenman, L., Papadopoulos, V., and Gavish, M. (2007) Channel-like functions of the 18-kDa Translocator protein (TSPO): regulation of apoptosis and steroidogenesis as part of the host-defense response Curr. Pharm. Des. 13, 2385-2405 (Pubitemid 47321571)
15. Decaudin, D., Castedo, M., Nemati, F., Beurdeley-Thomas, A., De Pinieux, G., Caron, A., Pouillart, P., Wijdenes, J., Rouillard, D., Kroemer, G., and Poupon, M.-F. (2002) Peripheral Benzodiazepine receptor ligands reverse apoptosis resistance of cancer cells in vitro and in vivo Cancer Res. 62, 1388-1393 (Pubitemid 34407797)
16. Kuhlmann, A. C. and Guilarte, T. R. (2000) Cellular and subcellular localization of peripheral benzodiazepine receptors after trimethyltin neurotoxicity J. Neurochem. 74, 1694-1704 (Pubitemid 30163992)
17. Maeda, J., Higuchi, M., Inaji, M., Ji, B., Haneda, E., Okauchi, T., Zhang, M. R., Suzuki, K., and Suhara, T. (2007) Phase-dependent roles of reactive microglia and astrocytes in nervous system injury as delineated by imaging of peripheral benzodiazepine receptor Brain Res. 1157, 100-111 (Pubitemid 46935074)
18. Shah, F., Hume, S. P., Pike, V. W., Ashworth, S., and McDermott, J. (1994) Synthesis of the enantiomers of [N-methyl-11C]PK 11195 and comparison of their behaviours as radioligands for PK binding sites in rats Nucl. Med. Biol. 21, 573-581 (Pubitemid 24173248)
19. Banati, R. B. (2002) Visualising microglial activation in vivo Glia 40, 206-217 (Pubitemid 35337378)
20. Schweitzer, P. J., Fallon, B. A., Mann, J. J., and Dileep Kumar, J. S. (2010) PET tracers for the peripheral benzodiazepine receptor and uses thereof Drug Discovery Today 15, 933-942
21. Cagnin, A., Gerhard, A., and Banati, R. B. (2002) In vivo imaging of neuroinflammation Eur. Neuropsychopharmacol. 12, 581-586 (Pubitemid 35408707)
22. Doorduin, J., deVries, E. F. J., Dierckx, R. A., and Klein, H. C. (2008) PET imaging of the peripheral benzodiazepine receptor: monitoring disease progression and therapy response in neurodegenerative disorders Curr. Pharm. Des. 14, 3297-3315
23. Owen, D. R. J. and Matthews, P. M. (2011) Imaging brain microglial activation using positron emission tomography and translocator protein-specific radioligands Int. Rev. Neurobiol. 101, 19-39
24. Groom, G. N., Junck, L., Foster, N. L., Frey, K. A., and Kuhl, D. E. (1995) PET of peripheral benzodiazepine binding sites in the microgliosis of Alzheimer's disease J. Nucl. Med. 36, 2207-2210
25. 11C]PIB-PET study Neurobiol. Dis. 32, 412-419
26. [11C](R)-PK11195 PET in idiopathic Parkinson's disease Neurobiol. Dis. 21, 404-412 (Pubitemid 43099863)
27. Banati, R. B., Newcombe, J., Gunn, R. N., Cagnin, A., Turkheimer, F., Heppner, F., Price, G., Wegner, F., Giovannoni, G., Miller, D. H., Perkin, G. D., Smith, T., Hewson, A. K., Bydder, G., Kreutzberg, G. W., Jones, T., Cuzner, M. L., and Myers, R. (2000) The peripheral benzodiazepine binding site in the brain in multiple sclerosis: quantitative in vivo imaging of microglia as a measure of disease activity Brain 123, 2321-2337
28. Politis, M., Giannetti, P., Su, P., Turkheimer, F., Keihaninejad, S., Wu, K., Waldman, A., Reynolds, R., Nicholas, R., and Piccini, P. (2010) Cortical microglial activation is associated with disability in secondary progressive multiple sclerosis: an in vivo imaging study Neurology 74 (Suppl. 2) A290
29. Thiel, A. and Heiss, W.-D. (2011) Imaging of microglia activation in stroke Stroke 42, 507-512
30. 11C](R)- PK11195 PET study Neuroimage 24, 591-595 (Pubitemid 41359057)
31. 11C]-R-PK11195 in patients with AIDS J. Neurovirol. 11, 346-355 (Pubitemid 41614514)
32. Wiley, C. A., Lopresti, B. J., Becker, J. T., Boada, F., Lopez, O. L., Mellors, J., Meltzer, C. C., Wisniewski, S. R., and Mathis, C. A. (2006) Positron emission tomography imaging of peripheral benzodiazepine receptor binding in humans immunodeficiency virus-infected subjects with and without cognitive impairment J. Neurovirol. 12, 262-271 (Pubitemid 44382978)
33. Lasiene, J. and Yamanaka, K. (2011) Glial cells in amyotrophic lateral sclerosis Neurol. Res. Int. 718987
34. Politis, M., Pavese, N., Tai, Y. F., Kiferle, L., Mason, S. L., Brooks, D. J., Tabrizi, S. J., Barker, R. A, and Piccini, P. (2011) Microglial activation in regions related to cognitive function predicts disease onset in Huntington's disease: A multimodal imaging study Human Brain Mapping 32, 258-270
35. Doorduin, J., De Vries, E. F. J., Willemsen, A. T. M., De Groot, J. C., Dierckx, R. A., and Klein, H. C. (2009) Neuroinflammation in schizophrenia-related psychosis A PET study J. Nucl. Med. 50, 1801-1807
36. Scarf, A. M. and Kassiou, M. (2011) The Translocator Protein J. Nucl. Med. 52, 677-680
37. Chauveau, F., Boutin, H., Van Camp, N., Thominiaux, C., Hantraye, P., Rivron, L., Marguet, F., Castel, M. N., Rooney, T., Benavides, J., Dollé, F., and Tavitian, B. (2011) In vivo imaging of neuroinflammation in the rodent brain with [11C]SSR180575, a novel indoleacetamide radioligand of the translocator protein (18 kDa) Eur. J. Nucl. Med. Mol. Imaging 38, 509-514
38. Gulyas, B., Toth, M., Vas, A., Shchukin, E., Kostulas, K., Hillert, J., and Halldin, C. (2012) Visualising neuroinflammation in post-stroke patients: a comparative PET study with the TSPO molecular imaging biomarkers [11C]PK11195 and [11C]vinpocetine Curr. Radiopharm. 1, 19-28
39. Owen, D. R., Gunn, R. N., Rabiner, E. A., Bennacef, I., Fujita, M., Kreisl, W. C., Innis, R. B., Pike, V. W., Reynolds, R., Matthews, P. M., and Parker, C. A. (2011) Mixed-affinity binding in humans with 18-kDa translocator protein ligands J. Nucl. Med. 52, 24-32
40. Yasuno, F., Ota, M., Kosaka, J., Ito, H., Higuchi, M., Doronbekov, T. K., Nozaki, S., Fujimura, Y., Koeda, M., Asada, T., and Suhara, T. (2008) Increased binding of peripheral benzodiazepine receptor in Alzheimer's disease measured by positron emission tomography with [11C]DAA1106 Biol. Psychiatry 64, 835-841
41. Dollé, F., Luus, C., Reynolds, A., and Kassiou, M. (2009) Radiolabelled molecules for imaging the Translocator protein (18 kDa) using positron emission tomography Curr. Med. Chem. 16, 2899-2923
42. Sekimata, K., Hatano, K., Ogawa, M., Abe, J., Magata, Y., Biggio, G., Serra, M., Laquintana, V., Denora, N., Latrofa, A., Trapani, G., Liso, G., and Ito, K. (2008) Radiosynthesis and in vivo evaluation of N-[11C]methylated imidazopyridineacetamides as PET tracers for peripheral benzodiazepine receptors Nucl. Med. Biol. 35, 327-334 (Pubitemid 351381968)
43. Endres, C. J., Pomper, M. G., James, M., Uzuner, O., Hammoud, D. A., Watkins, C. C., Reynolds, A., Hilton, J., Dannals, R. F., and Kassiou, M. (2009) Initial evaluation of 11C-DPA-713, a novel TSPO PET ligand in humans J. Nucl. Med. 50, 1276-1282
44. Yui, J., Hatori, A., Kawamura, K., Yanamoto, K., Yamasaki, T., Ogawa, M., Yoshida, Y., Kumata, K., Fujinaga, M., Nengaki, N., Fukumura, T., Suzuki, K., and Zhang, M. R. (2011) Visualization of early infarction in rat brain after ischemia using a translocator protein (18 kDa) PET ligand [11C]DAC with ultra-high specific activity Neuroimage 54, 123-130
45. Yui, J., Hatori, A., Yanamoto, K., Takei, M., Nengaki, N., Kumata, K., Kawamura, K., Yamasaki, T., Suzuki, K., and Zhang, M. R. (2010) Imaging of the translocator protein (18 kDa) in rat brain after ischemia using [11C]DAC with ultra-high specific activity Synapse 64, 488-493
46. Maeda, J., Zhang, M. R., Okauchi, T., Ji, B., Ono, M., Hattori, S., Kumata, K., Iwata, N., Saido, T. C., Trojanowski, J. Q., Lee, V. M., Staufenbiel, M., Tomiyama, T., Mori, H., Fukumura, T., Suhara, T., and Higuchi, M. (2011) In vivo positron emission tomographic imaging of glial responses to amyloid-beta and tau pathologies in mouse models of Alzheimer's disease and related disorders J. Neurosci. 31, 4720-4730
47. Dickstein, L. P., Zoghbi, S. S., Fujimura, Y., Imaizumi, M., Zhang, Y., Pike, V. W., Innis, R. B., and Fujita, M. (2011) Comparison of 18F- and 11C-labeled aryloxyanilide analogs to measure translocator protein in humans brain using positron emission tomography Eur. J. Nucl. Med. Mol. Imaging 38, 352-357
48. Rusjan, P. M., Wilson, A. A., Bloomfield, P. M., Vitcu, I., Meyer, J. H., Houle, S., and Mizrahi, R. (2011) Quantitation of translocator protein binding in humans brain with the novel radioligand [18F]-FEPPA and positron emission tomography J. Cereb. Blood Flow Metab. 31, 1807-1816
49. Tang, D., Hight, M. R., McKinley, E. T., Fu, A., Buck, J. R., Smith, R. A., Tantawy, M. N., Peterson, T. E., Colvin, D. C., Ansari, M. S., Nickels, M., and Manning, H. C. (2012) Quantitative preclinical imaging of TSPO expression in glioma using N,N-diethyl-2-(2-(4-(2-1 8F-fluoroethoxy)phenyl)-5,7- dimethylpyrazolo[1,5-a]pyrimidin-3-yl)acetamide J. Nucl. Med. 53, 287-294
50. Arlicot, N., Vercouillie, J., Ribeiro, M. J., Tauber, C., Venel, Y., Baulieu, J. L., Maia, S., Corcia, P., Stabin, M. G., Reynolds, A., Kassiou, M., and Guilloteau, D. (2012) Initial evaluation in healthy humans of [18F]DPA-714, a potential PET biomarker for neuroinflammation Nucl. Med. Biol. 39, 570-578
51. Van, C. N., Boisgard, R., Kuhnast, B., Theze, B., Viel, T., Gregoire, M. C., Chauveau, F., Boutin, H., Katsifis, A., Dollé, F., and Tavitian, B. (2010) In vivo imaging of neuroinflammation: a comparative study between [(18)F]PBR111, [(11)C]CLINME and [(11)C]PK11195 in an acute rodent model Eur. J. Nucl. Med. Mol. Imaging 37, 962-972
52. 18F]FEDAA1106- Selective radioligands for imaging TSPO18 kDa with PET: Automated radiosynthesis on a TRACERLAb FX-FN synthesizer and quality controls Appl. Radiat. Isot. 70, 489-497
53. Guo, Q., Brady, M., and Gunn, R. N. (2009) A biomathematical modeling approach to central nervous system radioligand discovery and development J. Nucl. Med. 50, 1715-1723
54. 13N radiolabels for Positron Emission Tomography Angew. Chem., Int. Ed. 47, 8998-9033
55. Levin, C. S. and Hoffman, E. J. (1999) Calculation of positron range and its effect on the fundamental limit of positron emission tomography system spatial resolution Phys. Med. Biol. 44, 781-799 (Pubitemid 29133069)
56. Wunder, A., Klohs, J., and Dirnagl, U. (2009) Non-invasive visualization of CNS inflammation with nuclear and optical imaging Neuroscience 158, 1161-1173
57. Ntziachristos, V. (2006) Fluorescence molecular imaging Annu. Rev. Biomed. Eng. 8, 1-33 (Pubitemid 44314811)
58. Hilderbrand, S. A. and Weissleder, R. (2010) Near-infrared fluorescence: application to in vivo molecular imaging Curr. Opin. Chem. Biol. 14, 71-79
59. Kozikowski, A. P., Kotoula, M., Ma, D., Boujrad, N., Tuckmantel, W., and Papadopoulos, V. (1997) Synthesis and biology of a 7-nitro-2,1,3-benzoxadiazol- 4-yl derivative of 2-phenylindole-3-acetamide: a fluorescent probe for the peripheral-type benzodiazepine receptor J. Med. Chem. 40, 2435-2439 (Pubitemid 27347006)
60. Chen, Y., Zheng, X., Dobhal, M. P., Gryshuk, A., Morgan, J., Dougherty, T. J., Oseroff, A., and Pandey, R. K. (2005) Methyl pyrophorbide-R analogues: potential fluorescent probes for the peripheral-type benzodiazepine receptor. Effect of central metal in photosensitizing efficacy J. Med. Chem. 48, 3692-3695 (Pubitemid 40776843)
61. Manning, H. C., Goebel, T., Marx, J. N., and Bornhop, D. J. (2002) Facile efficient conjugation of a trifunctional lanthanide chelate to a peripheral benzodiazepine receptor ligand Org. Lett. 4, 1075-1078
62. Manning, H. C., Goebel, T., Thompson, R. C., Price, R. R., Lee, H., and Bornhop, D. J. (2004) Targeted molecular imaging agents for cellular-scale bimodal imaging Bioconjugate Chem. 15, 1488-1495 (Pubitemid 39552041)
63. Manning, H. C., Smith, S. M., Sexton, M., Haviland, S., Bai, M., Cederquist, K., Stella, N., and Bornhop, D. J. (2006) A peripheral benzodiazepine receptor targeted agent for in vitro imaging and screening Bioconjugate Chem. 17, 735-740 (Pubitemid 43794384)
64. Bai, M., Wyatt, S., Han, Z., Papadopoulos, V., and Bornhop, D. J. (2007) A novel conjugable translocator protein ligand with a fluorescent dye for in vitro imaging Bioconjugate Chem. 18, 1118-1122 (Pubitemid 47122632)
65. Bai, M., Rone, M. B., Papadopoulos, V., and Bornhop, D. J. (2007) A novel functional translocator protein ligand for cancer imaging Bioconjugate Chem. 18, 2018-2023 (Pubitemid 350220003)
66. Wyatt, S. K., Manning, H. C., Bai, M., Bailey, S. N., Gallant, P., Ma, G., McIntosh, L., and Bornhop, D. J. (2010) Molecular imaging of the Translocator Protein (TSPO) in a pre-clinical model of breast cancer Mol. Imaging Biol. 12, 349-358
67. Deo, A. K, Theil, F. P., and Nicolas, J. M. (2013) Confounding parameters in preclinical assessment of Blood-Brain Barrier permeation: an overview with emphasis on species differences and effect of disease states Mol. Pharmaceutics 10, 1581-1595
68. Denora, N., Trapani, A., Laquintana, V., Lopedota, A., and Trapani, G. (2009) Recent advances in medicinal chemistry- and pharmaceutical technology-strategies for drug delivery to the brain Curr. Top. Med. Chem. 9, 182-196
69. Trapani, G., Laquintana, V., Denora, N., Trapani, A., Lopedota, A., Latrofa, A., Franco, M., Serra, M., Pisu, M. G., Floris, I., Sanna, E., Biggio, G., and Liso, G. (2005) Structure-activity relationships and effects on neuroactive steroid synthesis in a series of 2-phenylimidazo[1,2-a] pyridineacetamide peripheral benzodiazepine receptors ligands J. Med. Chem. 48, 292-305 (Pubitemid 40105268)
70. Laquintana, V., Denora, N., Lopedota, A., Suzuki, H., Sawada, M., Serra, M., Biggio, G., Latrofa, A., Trapani, G., and Liso, G. (2007) N -Benzyl-2-(6,8-dichloro-2-(4-chlorophenyl)imidazo[1,2-a] pyridin-3-yl)-N-(6- (7-nitrobenzo[c][1,2,5]oxadiazol-4-ylamino) hexyl)acetamide as a new fluorescent probe for peripheral benzodiazepine receptor and microglial cell visualization Bioconjugate Chem. 18, 1397-1407 (Pubitemid 47464046)
71. Clark, D. E. (1999) Rapid calculation of polar molecular surface area and its application to the prediction of transport phenomena. 2. Prediction of blood-brain barrier penetration J. Pharm. Sci. 88, 815-821 (Pubitemid 29398551)
72. Denora, N., Laquintana, V., Pisu, M. G., Dore, R., Murru, L., Latrofa, A., Trapani, G., and Sanna, E. (2008) 2-Phenyl-imidazo[1,2-a]pyridine compounds containing hydrophilic groups as potent and selective ligands for peripheral benzodiazepine receptors: synthesis, binding affinity and electrophysiological studies J. Med. Chem. 51, 6876-88
73. Denora, N., Laquintana, N., Trapani, A., Suzuki, H., Sawada, M., and Trapani, G. (2011) New fluorescent probes targeting the mitochondrial-located translocator protein 18 kDa (TSPO) as activated microglia imaging agents Pharm. Res. 28, 2820-2832
74. Taliani, S., Simorini, F., Sergianni, V., La Motta, C., Da Settimo, F., Cosimelli, B., Abignente, E., Greco, G., Novellino, E., Rossi, L., Gremigni, V., Spinetti, F., Chelli, B., and Martini, C. (2007) New fluorescent 2-phenylindolglyoxylamide derivatives as probes targeting the peripheral-type benzodiazepine receptor: design, synthesis, and biological evaluation J. Med. Chem. 50, 404-407 (Pubitemid 46147722)
75. Taliani, S., Da Pozzo, E., Bellandi, M., Bendinelli, S., Pugliesi, I., Simorini, F., La Motta, C., Salerno, S., Marini, A. M., Da Settimo, F., Cosimelli, B., Greco, G., Novellino, E., and Martini, C. (2010) Novel irreversible fluorescent probes targeting the 18 kDa translocator protein: synthesis and biological characterization J. Med. Chem. 53, 4085-4093
76. Mensch, J., Oyarzabal, J., Mackie, C., and Augustijns, P. (2009) In vivo, in vitro and in silico methods for small molecule transfer across the BBB J. Pharm. Sci. 98, 4429-4468
77. Samuelson, L. E., Dukes, M. J., Hunt, C. R., Casey, J. D., and Bornhop, D. J. (2009) TSPO targeted dendrimer imaging agent: synthesis, characterization and cellular internalization Bioconjugate Chem. 20, 2082-2089
78. Lammers, T., Kiessling, F., Hennink, W. E., and Storm, G. (2010) Nanotheranostics and image-guided drug delivery: current concepts and future directions Mol. Pharmaceutics 7, 1899-1912
79. Bhojani, M. S., Van Dort, M., Rehemtulla, A., and Ross, B. D. (2010) Targeted imaging and therapy of brain cancer using theranostic nanoparticles Mol. Pharmaceutics 7, 1921-1929
80. Perez-Martinez, F. C., Ocaña, A. V., Perez-Carrion, M. D., and Ceña, V. (2012) Dendrimers as vectors for genetic material delivery to the Nervous System Curr. Med. Chem. 19, 5101-5108
81. Tosi, G., Costantino, L., Ruozi, B., Forni, F., and Vandelli, M. A. (2008) Polymeric nanoparticles for the drug delivery to the central nervous system Expert Opin. Drug Delivery 5, 155-174 (Pubitemid 351308309)
82. Mistry, A., Stolnik, S., and Illum, L. (2009) Nanoparticles for direct nose-to-brain delivery of drugs Int. J. Pharm. 379, 146-157
83. Blasi, P., Giovagnoli, S., Schoubben, A., Ricci, M., and Rossi, C. (2007) Solid lipid nanoparticles for targeted brain drug delivery Adv. Drug Delivery Rev. 59, 454-477 (Pubitemid 47259226)